Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs aimed toward expanding the horizons of cytokine-based immunotherapy, specifically for cancers where treatment method alternatives remain limited. Use the links below to learn extra about our portfolio of cytokine-based immunotherapy candidates. Examine Our Pipeline https://financefeeds.com/shiba-inu-price-prediction-will-shib-continue-tumbling-in-2025-as-investors-turn-to-this-0-20-alternative/